List view / Grid view
Celeste Maksim, Chief of Staff, Clinical and Post-Market Practice, RQM+ advises on strategising for PMCF compliance, highlighting areas to prioritise to ensure an efficient process.
Discover how to plan for post‑market clinical follow-up compliance under the new EU Medical Device Regulation (MDR), and formulate live biotherapeutic products to enhance their effects in this in-depth focus.
Adare’s Optimµm® technology offers a unique and efficient method of fabricating monodisperse microparticles at reduced development time.
Using a proprietary Stratµm TM technology, we have created 50 µm capsules with an aqueous core and thin PLA shell.
Parvulet™ Technology is a patented oral dosage form capable of being dispensed to patients in tablet or powders, and converted into a semi-solid with water.
Improved drug delivery with precision particle fabrication-enabling precise control over particle structure.
Expanding solutions for challenging APIs through the coacervation process.
MMTS Mini tabs delivers child-friendly, broad-range dosing for toddlers.
Microcaps exceeds stringent requirements beyond taste masking.
Case study example regarding finding impurities and controlling formations at release.
Overview of Adare Pharma Solutions- a leading global CDMO with innovative oral dose technology platforms.
